ODN 2006-Type B (human, Negative Control) (VAdv-Ly0070)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| VAdv-Ly0070 |
|
ODN 2006-Type B, human TLR9 agonist, oligodeoxynucleotide vaccine adjuvant.
Datasheet
Specifications
Type
CpG
Molecular Weight
7720
Specificity
TLR9 agonist
Product Form
Powder
Percentage
≥ 95%
Endotoxin
Lower than 0.1 EU/mg.
Storage
Store at -20°C.
Shelf Life
1 year.
Adjuvant Information
Introduction
ODN 2006 is a type B human TLR9 agonist. It induces the MAP kinase pathway and NFκB translocation in purified B cells and could be a potent adjuvant to support humoral immune responses in primates.
Sequence
5'-tgctgcttttgtgcttttgtgctt-3' (24 mer)
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
